Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-1.00%)
Close on Nov 18, 2026Market cap $452.45KP/E –Yield –
Arcadia Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Arcadia Biosciences's revenue for the twelve months ending Jun 30, 2026 was $4.75M, down 12.2% year over year. For fiscal 2025 it was $4.86M, down 3.7% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $8.03M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.86M | -3.7% |
| FY2024 | Dec 31, 2024 | $5.05M | +13.3% |
| FY2023 | Dec 31, 2023 | $4.45M | -40.0% |
| FY2022 | Dec 31, 2022 | $7.42M | +9.4% |
| FY2021 | Dec 31, 2021 | $6.78M | -15.6% |
| FY2020 | Dec 31, 2020 | $8.03M | +587.3% |
| FY2019 | Dec 31, 2019 | $1.17M | -20.2% |
| FY2018 | Dec 31, 2018 | $1.46M | -63.6% |
| FY2017 | Dec 31, 2017 | $4.03M | +26.3% |
| FY2016 | Dec 31, 2016 | $3.19M | -41.1% |
| FY2015 | Dec 31, 2015 | $5.41M | -22.5% |
| FY2014 | Dec 31, 2014 | $6.98M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.44M | -0.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.10M | -8.3% |
| Q4 FY2025 | Dec 31, 2025 | $901.00K | -25.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.30M | -15.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.46M | +11.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.20M | +21.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.22M | +56.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.54M | +18.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.31M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | $987.00K | -19.9% |
| Q4 FY2023 | Dec 31, 2023 | $777.00K | +4.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.30M | -17.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.30M | -66.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.23M | -61.7% |
| Q4 FY2022 | Dec 31, 2022 | $744.00K | -65.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.57M | -33.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.86M | +174.6% |
| Q1 FY2022 | Mar 31, 2022 | $3.22M | +288.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.17M | -69.6% |
| Q3 FY2021 | Sep 30, 2021 | $2.38M | +656.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.41M | +400.0% |
| Q1 FY2021 | Mar 31, 2021 | $828.00K | +168.0% |
| Q4 FY2020 | Dec 31, 2020 | $7.13M | +1613.9% |
| Q3 FY2020 | Sep 30, 2020 | $314.00K | -19.9% |
| Q2 FY2020 | Jun 30, 2020 | $281.00K | +38.4% |
| Q1 FY2020 | Mar 31, 2020 | $309.00K | +95.6% |
| Q4 FY2019 | Dec 31, 2019 | $416.00K | -6.3% |
| Q3 FY2019 | Sep 30, 2019 | $392.00K | +5.9% |
| Q2 FY2019 | Jun 30, 2019 | $203.00K | -53.4% |
| Q1 FY2019 | Mar 31, 2019 | $158.00K | -26.2% |
| Q4 FY2018 | Dec 31, 2018 | $444.00K | -68.9% |
| Q3 FY2018 | Sep 30, 2018 | $370.00K | -37.2% |
| Q2 FY2018 | Jun 30, 2018 | $436.00K | -56.0% |
| Q1 FY2018 | Mar 31, 2018 | $214.00K | -79.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.43M | +164.4% |
| Q3 FY2017 | Sep 30, 2017 | $589.00K | -45.2% |
| Q2 FY2017 | Jun 30, 2017 | $991.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $540.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.08M | – |
See a number that looks wrong?